Business
See which junior ASX biotech is rocketing 63% higher on good news
Image source: Getty Images
Shares in junior biotech company Starpharma Holdings Ltd (ASX: SPL) are up more than 63% after the firm announced a collaboration and license agreement with major drug company Genentech, which could lead to success payments of up to US$564 million.
Starpharma will…
Continue Reading